President Donald Trump is pushing ahead with announcements to TrumpRx.gov as Americans look for ways to cut the costs associated with prescription drugs.

New research suggests GLP-1 drugs may increase the risk of bone and tendon injuries and other conditions, including ...

Jayant Mishra said he was approved for a copay card covering $9,450 a year. He didn't realize how fast the money would run out.

Amgen Inc. and GSK plc are reportedly set to announce their partnership with TrumpRx.gov. This collaboration is set to offer ...

Johnson & Johnson's much-anticipated oral IL-23 inhibitor, icotrokinra, has claimed FDA approval as a first-line treatment for plaque psoriasis.

Ayurveda is a comprehensive therapy as it aims at reducing inflammation, enhancing digestion, stabilizing the equilibrium with herbs, diet, detoxification and lifestyle changes to maintain the immune ...

Bristol Myers BMY recently secured a meaningful label expansion for Sotyktu, with the FDA approving the drug for adults with ...

GLP-1 receptor agonists like semaglutide are being used off-label by healthy people hoping to slow ageing, despite limited evidence and unknown long-term risks.

OUR resident specialist and NHS GP, Dr Zoe Williams, shares her expert advice. Today, Dr Zoe helps a reader who has recently been diagnosed with osteoarthritis in their feet and hips.

In one corner: U.S. consumers fed up with high drug prices. In the other: pharmaceutical companies arguing that price controls stifle innovation. ‘The Other Drug War,’ a 2003 documentary tracing the ...

Johnson & Johnson JNJ rapidly advanced its pipeline in 2025, attaining significant clinical and regulatory milestones that will help drive growth through the back half of the decade. In 2025, it ...

Debates around the boundaries of medicine, law and personal autonomy took centre stage, and after a significant ruling by the ...